Treatment Of Multiple Sclerosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
VCNX | D | Vaccinex, Inc. | -3.59 | |
ALKS | D | Alkermes plc | 0.17 | |
CGEN | F | Compugen Ltd. | -1.18 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Multiple Sclerosis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | F | AdvisorShares Psychedelics ETF | 4.94 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 3.99 | |
PSCH | D | PowerShares S&P SmallCap Health Care Portfolio | 3.41 | |
FBT | B | First Trust Amex Biotech Index Fund | 3.14 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 3.1 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jul 2 | CGEN | The past three years for Compugen (NASDAQ:CGEN) investors has not been profitable |
Related Industries:
Biotechnology
- Treatment Of Multiple Sclerosis
Treatment of multiple sclerosis (MS) is aimed at reducing the frequency and severity of attacks, slowing the progression of the disease, and managing symptoms. Treatment options may include medications, physical therapy, occupational therapy, lifestyle changes, and assistive devices.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles